Barri, Mark Zian P.

HRN: 22-57-56  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/05/2023
OXACILLIN 500MG (VIAL)
02/05/2023
02/12/2023
IV
45mg
Q6 Hours
Seborrheic Dermatitis With Bacterial Infection
Waiting Final Action 
02/05/2023
CEFTAZIDIME 1GM (VIAL)
02/05/2023
02/12/2023
IV
60mg
Q8hours
Seborrheic Dermatitis With Bacterial Infection; PCAP-B
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: